MedPage Today

Another Push for Upfront Ezetimibe-Statin Combo Soon After MI

A Swedish database of over 35,000 individuals found better cardiovascular outcomes when ezetimibe was added earlier to statin therapy for secondary prevention. Study authors deemed ezetimibe a ...
Healio

Obicetrapib plus ezetimibe halves LDL for patients at high atherosclerotic risk

Please provide your email address to receive an email when new articles are posted on . Obicetrapib plus ezetimibe lowered LDL nearly 50% vs. placebo in patients with high atherosclerotic risk.
News Medical

Combining ezetimibe and bempedoic acid effectively lowers cholesterol in statin-intolerant patients

A recent simulation study published in the journal Scientific Reports analyzed representative data of over two million outpatients in Germany, in which the researchers reported that a combination of ...
Healio

Ezetimibe did not increase diabetes risk in IMPROVE-IT substudy

Please provide your email address to receive an email when new articles are posted on . Ezetimibe conferred no increased risk for new-onset diabetes among IMPROVE-IT participants. The findings were ...
Seeking Alpha

First-In-Class Cholesterol-Lowering Treatment NILEMDO® (NEXLETOL® in the U.S.) and Its Combination with Ezetimibe, NUSTENDI® (NEXLIZET® in the U.S.), Approved In Europe To ...

– NILEMDO (bempedoic acid), a First-In-Class, Oral Treatment and NUSTENDI (bempedoic Acid / Ezetimibe Fixed-Dose Combination) Receive Label Update Approval from The European Commission as Treatments ...